These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 17490877)

  • 1. Himbacine derived thrombin receptor antagonists: discovery of a new tricyclic core.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Lin Y; Tagat JR; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Hsieh Y; McPhail AT
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3647-51. PubMed ID: 17490877
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of potent orally active thrombin receptor (protease activated receptor 1) antagonists as novel antithrombotic agents.
    Chackalamannil S; Xia Y; Greenlee WJ; Clasby M; Doller D; Tsai H; Asberom T; Czarniecki M; Ahn HS; Boykow G; Foster C; Agans-Fantuzzi J; Bryant M; Lau J; Chintala M
    J Med Chem; 2005 Sep; 48(19):5884-7. PubMed ID: 16161991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of a novel, orally active himbacine-based thrombin receptor antagonist (SCH 530348) with potent antiplatelet activity.
    Chackalamannil S; Wang Y; Greenlee WJ; Hu Z; Xia Y; Ahn HS; Boykow G; Hsieh Y; Palamanda J; Agans-Fantuzzi J; Kurowski S; Graziano M; Chintala M
    J Med Chem; 2008 Jun; 51(11):3061-4. PubMed ID: 18447380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Himbacine derived thrombin receptor (PAR-1) antagonists: SAR of the pyridine ring.
    Xia Y; Chackalamannil S; Clasby M; Doller D; Eagen K; Greenlee WJ; Tsai H; Agans-Fantuzzi J; Ahn HS; Boykow GC; Hsieh Y; Lunn CA; Chintala M
    Bioorg Med Chem Lett; 2007 Aug; 17(16):4509-13. PubMed ID: 17574850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterotricyclic himbacine analogs as potent, orally active thrombin receptor (protease activated receptor-1) antagonists.
    Chelliah MV; Chackalamannil S; Xia Y; Eagen K; Clasby MC; Gao X; Greenlee W; Ahn HS; Agans-Fantuzzi J; Boykow G; Hsieh Y; Bryant M; Palamanda J; Chan TM; Hesk D; Chintala M
    J Med Chem; 2007 Oct; 50(21):5147-60. PubMed ID: 17854166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of nor-seco himbacine analogs as thrombin receptor antagonists.
    Chelliah MV; Chackalamannil S; Xia Y; Eagen K; Greenlee WJ; Ahn HS; Agans-Fantuzzi J; Boykow G; Hsieh Y; Bryant M; Chan TM; Chintala M
    Bioorg Med Chem Lett; 2012 Apr; 22(7):2544-9. PubMed ID: 22405832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Himbacine derived thrombin receptor (PAR-1) antagonists: structure-activity relationship of the lactone ring.
    Xia Y; Chackalamannil S; Chan TM; Czarniecki M; Doller D; Eagen K; Greenlee WJ; Tsai H; Wang Y; Ahn HS; Boykow GC; McPhail AT
    Bioorg Med Chem Lett; 2006 Sep; 16(18):4969-72. PubMed ID: 16824760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombin receptor (protease activated receptor-1) antagonists as potent antithrombotic agents with strong antiplatelet effects.
    Chackalamannil S
    J Med Chem; 2006 Sep; 49(18):5389-403. PubMed ID: 16942011
    [No Abstract]   [Full Text] [Related]  

  • 9. Metabolism-based identification of a potent thrombin receptor antagonist.
    Clasby MC; Chackalamannil S; Czarniecki M; Doller D; Eagen K; Greenlee W; Kao G; Lin Y; Tsai H; Xia Y; Ahn HS; Agans-Fantuzzi J; Boykow G; Chintala M; Foster C; Smith-Torhan A; Alton K; Bryant M; Hsieh Y; Lau J; Palamanda J
    J Med Chem; 2007 Jan; 50(1):129-38. PubMed ID: 17201416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Himbacine analogs as muscarinic receptor antagonists--effects of tether and heterocyclic variations.
    Chackalamannil S; Doller D; McQuade R; Ruperto V
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3967-70. PubMed ID: 15225708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of a vorapaxar analog with increased aqueous solubility.
    Xia Y; Chackalamannil S; Greenlee WJ; Wang Y; Hu Z; Root Y; Wong J; Kong J; Ahn HS; Boykow G; Hsieh Y; Kurowski S; Chintala M
    Bioorg Med Chem Lett; 2010 Nov; 20(22):6676-9. PubMed ID: 20888225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of a nonpeptidic small molecule antagonist of the human platelet thrombin receptor (PAR-1).
    Nantermet PG; Barrow JC; Lundell GF; Pellicore JM; Rittle KE; Young M; Freidinger RM; Connolly TM; Condra C; Karczewski J; Bednar RA; Gaul SL; Gould RJ; Prendergast K; Selnick HG
    Bioorg Med Chem Lett; 2002 Feb; 12(3):319-23. PubMed ID: 11814787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
    Miller JH; Aagaard PJ; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C(4)-alkyl substituted furanyl cyclobutenediones as potent, orally bioavailable CXCR2 and CXCR1 receptor antagonists.
    Chao J; Taveras AG; Chao J; Aki C; Dwyer M; Yu Y; Purakkattle B; Rindgen D; Jakway J; Hipkin W; Fosetta J; Fan X; Lundell D; Fine J; Minnicozzi M; Phillips J; Merritt JR
    Bioorg Med Chem Lett; 2007 Jul; 17(13):3778-83. PubMed ID: 17459706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity relationships of some Galbulimima alkaloids related to himbacine.
    Darroch SA; Taylor WC; Choo LK; Mitchelson F
    Eur J Pharmacol; 1990 Jun; 182(1):131-6. PubMed ID: 2401311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CCR5 receptor antagonists: discovery and SAR of novel 4-hydroxypiperidine derivatives.
    Lu SF; Chen B; Davey D; Dunning L; Jaroch S; May K; Onuffer J; Phillips G; Subramanyam B; Tseng JL; Wei RG; Wei M; Ye B
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1883-7. PubMed ID: 17314043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design, synthesis, and structure-activity relationship studies of himbacine derived muscarinic receptor antagonists.
    Doller D; Chackalamannil S; Czarniecki M; McQuade R; Ruperto V
    Bioorg Med Chem Lett; 1999 Mar; 9(6):901-6. PubMed ID: 10206558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and muscarinic M(2) subtype antagonistic activity of enantiomeric pairs of 3-demethylhimbacine (3-norhimbacine) and its C(4)-epimer.
    Takadoi M; Yamaguchi K; Terashima S
    Bioorg Med Chem Lett; 2002 Nov; 12(22):3271-3. PubMed ID: 12392730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of himbacine with carbachol at muscarinic receptors of heart and smooth muscle.
    Gilani SA; Cobbin LB
    Arch Int Pharmacodyn Ther; 1987 Nov; 290(1):46-53. PubMed ID: 3446043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SCH 530348: a novel oral thrombin receptor antagonist.
    Bonaca MP; Morrow DA
    Future Cardiol; 2009 Sep; 5(5):435-42. PubMed ID: 19715408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.